Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

[1]  S. Lowe,et al.  Tumor Cell‐Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy , 2018, Immunity.

[2]  R. Weinberg,et al.  The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy , 2018, Science Translational Medicine.

[3]  Z. Werb,et al.  Innate and acquired immune surveillance in the postdissemination phase of metastasis , 2018, The FEBS journal.

[4]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[5]  D. Xiu,et al.  Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study , 2017, Cancer management and research.

[6]  H. Kubo,et al.  Primary Tumors Limit Metastasis Formation through Induction of IL15-Mediated Cross-Talk between Patrolling Monocytes and NK Cells , 2017, Cancer Immunology Research.

[7]  Q. Gou,et al.  Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China , 2017, Medicine.

[8]  Rostyslav V Bubnov,et al.  “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer Syndrome” relevance to address the question , 2017, EPMA Journal.

[9]  M. Thangaraju,et al.  Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade , 2017, Nature Communications.

[10]  Thomas R. Cox,et al.  Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.

[11]  Rainer Spang,et al.  Early dissemination seeds metastasis in breast cancer , 2016, Nature.

[12]  J. Condeelis,et al.  Mechanism of early dissemination and metastasis in Her2+ mammary cancer , 2016, Nature.

[13]  M. Disis,et al.  Clinical significance of tumor-infiltrating lymphocytes in breast cancer , 2016, Journal of Immunotherapy for Cancer.

[14]  Jiusheng Deng,et al.  Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein. , 2016, Cancer research.

[15]  J. Ursini-Siegel,et al.  The influence of the pre-metastatic niche on breast cancer metastasis. , 2016, Cancer letters.

[16]  M. Degli-Esposti,et al.  “Natural Regulators”: NK Cells as Modulators of T Cell Immunity , 2016, Front. Immunol..

[17]  Tao Zhang,et al.  Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis , 2016, Oncotarget.

[18]  S. Ugel,et al.  Tumor-Induced Myeloid-Derived Suppressor Cells , 2016, Microbiology spectrum.

[19]  Y. Mao,et al.  The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis , 2016, PloS one.

[20]  R. Weinberg,et al.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. , 2016, Cancer discovery.

[21]  D. Gabrilovich,et al.  The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. , 2016, Trends in immunology.

[22]  Xuetao Cao,et al.  Immunosuppressive cells in tumor immune escape and metastasis , 2016, Journal of Molecular Medicine.

[23]  A. Azmi,et al.  Immune evasion in cancer: Mechanistic basis and therapeutic strategies. , 2015, Seminars in cancer biology.

[24]  Dapeng Li,et al.  Primary Tumor Resection Is Associated with Improved Survival in Stage IV Colorectal Cancer: An Instrumental Variable Analysis , 2015, Scientific Reports.

[25]  Steven J. M. Jones,et al.  Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer , 2015, Cell.

[26]  R. Hoffman,et al.  Surgically-Induced Multi-organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer. , 2015, Anticancer research.

[27]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. , 2015, The Journal of clinical investigation.

[28]  G. Tanriover,et al.  Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response , 2014, Oncogene.

[29]  Dong Wang,et al.  Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts , 2013, Stem cell reports.

[30]  S. Spiegel,et al.  Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. , 2013, Surgery.

[31]  A. G. Boef,et al.  [Instrumental variable analysis]. , 2013, Nederlands tijdschrift voor geneeskunde.

[32]  M. Wicha,et al.  Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. , 2012, Molecular cell.

[33]  G. M. Nagaraja,et al.  A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease , 2012, BMC Cancer.

[34]  Qiang Hu,et al.  Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism , 2011, PloS one.

[35]  Max S Wicha,et al.  Breast cancer stem cells, cytokine networks, and the tumor microenvironment. , 2011, The Journal of clinical investigation.

[36]  R. Schreiber,et al.  Cancer Immunoediting of the NK Group 2D Ligand H60a , 2011, The Journal of Immunology.

[37]  Lewis L. Lanier,et al.  NK cell development, homeostasis and function: parallels with CD8+ T cells , 2011, Nature Reviews Immunology.

[38]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[39]  C. Alam,et al.  Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes , 2011, European journal of immunology.

[40]  T. Cotter,et al.  Surgical Injury Enhances the Expression of Genes That Mediate Breast Cancer Metastasis to the Lung , 2010, Annals of surgery.

[41]  J. Abastado,et al.  Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. , 2010, The Journal of clinical investigation.

[42]  Larry Norton,et al.  Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.

[43]  Y. Meng,et al.  G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models , 2009, Proceedings of the National Academy of Sciences.

[44]  C. Klein,et al.  Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.

[45]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[46]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[47]  G. Babiera,et al.  Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988-2003 SEER Data , 2008 .

[48]  G. Hortobagyi,et al.  Timing of Surgical Intervention for the Intact Primary in Stage IV Breast Cancer Patients , 2008, Annals of Surgical Oncology.

[49]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[50]  F. Schmidt.  Meta-Analysis , 2008 .

[51]  Peisheng Zhang,et al.  Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. , 2007, Cancer research.

[52]  D. Jeffe,et al.  Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data , 2007, Annals of Surgical Oncology.

[53]  Robert D. Schreiber,et al.  Interferons, immunity and cancer immunoediting , 2006, Nature Reviews Immunology.

[54]  G. Vlastos,et al.  Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  Gavin P Dunn,et al.  Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. , 2006, Advances in immunology.

[56]  J. Flynn,et al.  Long-Term Control of Mycobacterium tuberculosis Infection Is Mediated by Dynamic Immune Responses1 , 2005, The Journal of Immunology.

[57]  P. Sinha,et al.  Surgical Removal of Primary Tumor Reverses Tumor-Induced Immunosuppression Despite the Presence of Metastatic Disease , 2004, Cancer Research.

[58]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[59]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[60]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[61]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.

[62]  N. Flomenberg,et al.  Differential expression and regulation of the human CD8a and CD8 chains , 1990 .

[63]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .

[64]  L. Terry,et al.  Differential expression and regulation of the human CD8 alpha and CD8 beta chains. , 1990, Tissue antigens.